Paper by Piro Lito et al shows new tricomplex RAS inhibitors "inactivate mutant RAS in a bimodal manner: by preventing effectors from being recruited to active state of RAS and/or by enhancing the ability of RAS mutants to hydrolyze GTP leading to their inactivation." https://www.nature.com/articles/s41586-024-08283-2